Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow 0.00% Nasdaq Up0.52%

Cesca Therapeutics Inc. (KOOL)

2.06 0.46(28.75%) Apr 24, 4:00PM EDT
|After Hours : 2.12 Up 0.06 (2.91%) Apr 24, 7:58PM EDT
Get the big picture on all your investments.
ProfileGet Profile for:
Cesca Therapeutics Inc.
2711 Citrus Road
Rancho Cordova, CA 95742
United States - Map
Phone: 916-858-5100
Fax: 916-858-5199

Index Membership:N/A
Industry:Medical Appliances & Equipment
Full Time Employees:66

Business Summary 

Cesca Therapeutics Inc. designs, develops, and commercializes devices and disposable tools for the processing, storage, and administration of cell therapies. It provides automated and semi-automated devices, and single-use processing disposables that enable hospitals and blood banks to manufacture a therapeutic dose of stem cells. The company offers the AXP System, a medical device that isolates and retrieves stem cells from umbilical cord blood; the BioArchive System, a robotic cryogenic medical device used to cryopreserve and archive stem cells for transplant and treatment; Res-Q 60 BMC, a device used for the isolation and extraction of specific stem cell populations from bone marrow; the MarrowXpress or MXP System that isolates and concentrates stem cells from bone marrow; and Res-Q 60 PRP, which is used for the preparation of autologous platelet rich plasma from a sample of blood at the point of care. It was formerly known as ThermoGenesis Corp. and changed its name to Cesca Therapeutics Inc. in February 2014. The company was founded in 1986 and is headquartered in Rancho Cordova, California.

Key Statistics

Company Websites 
Home Page
Search Yahoo! for:
More on Cesca Therapeutics Inc.

Key Executives 
Mr. Matthew T. Plavan , 50
Chief Exec. Officer and Director
Mr. Dan T. Bessey , 49
Chief Financial Officer and Principal Accounting Officer
Mr. Kevin D. Cooksy J.D., 52
VP of Corp. Devel. & Scientific Affairs
Mr. Kenneth A. Pappa , 53
VP of Manufacturing, Engineering and IT
Mr. Kenneth L. Harris , 50
Pres and Director
Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in USD.
View Insiders